Artery Carotid Articles & Analysis
30 news found
Good news from vascular medicine: the innovative drug Revacept can protect people with narrowed carotid arteries from both further strokes and dangerous bleeding. Thanks to this completely new dual efficacy, Revacept is ideal for preventing complications after stroke prevention surgery on narrowed carotid arteries. ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate the body's baroreflex, which in turn triggers an autonomic response to the heart. ...
ByCVRx
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
In June, Anteris' finished the proof-of-concept animal study on conduits treated with its Adapt tissue technology in the carotid artery. Conduits treated with the Adapt process showed no evidence of calcification as indicated by histopathology. ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., ...
Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate the body's baroreflex, which in turn triggers an autonomic response to the heart. ...
ByCVRx
At Beth Israel Deaconess, going forward, we expect that the right treatment for the majority of our atherosclerotic carotid disease patients will be TCAR.” About Silk Road Medical’s TCAR Procedure with the ENROUTE Transcarotid Neuroprotection and Stent System TransCarotid Artery Revascularization is our clinically proven procedure combining surgical ...
The program will begin with a clinical study into the treatment of carotid artery disease using R-One™, the first robotic platform developed by Robocath, which has been on the market since 2019. ...
ByRobocath
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that evaluated the peri-procedural and 30-day silent brain infarcts associated with the ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces it will report third quarter 2021 financial results on Tuesday, November 9, 2021, before the market opens. ...
Some of the first applications to be commercialized include scanning carotid arteries to assess the risk for stroke, the thyroid and breast to determine whether detected nodules may be malignant, and even assessing and monitoring osteoarthritis and rheumatoid arthritis in the knee, wrist or other parts of the body. ...
(Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system has received a positive opinion from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results as of and for the second quarter ended June 30, 2021. ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS. ...
The presentation: Expansion of Transcarotid Artery Revascularization to Standard Risk Patients for Treatment of Carotid Artery Stenosis, will be shared by Dr. ...